# Maragogype Coffee (Coffea arabica 'Maragogype')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/maragogype-coffee
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Coffee Cultivars
**Also Known As:** Elephant Bean Coffee, Giant Bean Coffee, Maragogipe Coffee, Large Bean Arabica, Typica Maragogype, Brazilian Elephant Bean, Jumbo Coffee Bean

## Overview

Maragogype coffee (Coffea arabica 'Maragogype') is a large-bean Arabica cultivar originating from Maragogipe, Brazil, containing caffeine, chlorogenic acids, and diterpenes such as cafestol and kahweol as its primary bioactive compounds. These compounds inhibit enzymes like monoamine oxidase (MAO) and modulate glucose-6-phosphatase activity, mechanisms attributed to general Arabica coffee research rather than Maragogype-specific clinical data.

## Health Benefits

• No specific health benefits documented - No clinical trials exist for Maragogype coffee specifically
• General Arabica coffee associated with reduced type 2 diabetes risk - Evidence from general coffee research, not Maragogype-specific studies
• General Arabica coffee linked to reduced Parkinson's disease risk - Based on broader coffee research, no isolated Maragogype data
• Contains standard coffee [antioxidant](/ingredients/condition/antioxidant)s (chlorogenic acids) - Assumed presence based on Arabica profile, no quantitative data
• Natural sugar content may provide energy - Based on noted high sugar content in beans, no clinical evidence

## Mechanism of Action

Chlorogenic acids found in Arabica cultivars including Maragogype inhibit glucose-6-phosphatase in the liver, reducing hepatic glucose output and potentially lowering type 2 diabetes risk. Caffeine and its metabolites (paraxanthine, theobromine) antagonize adenosine A1 and A2A receptors in the brain, which underlies the [neuroprotective](/ingredients/condition/cognitive) associations observed in Parkinson's disease epidemiology. Diterpenes cafestol and kahweol activate the Nrf2 [antioxidant](/ingredients/condition/antioxidant) pathway and modulate [phase II detox](/ingredients/condition/detox)ification enzymes, though these effects are reduced in filtered preparations.

## Clinical Summary

No clinical trials have been conducted specifically on Maragogype coffee as a distinct cultivar, making cultivar-specific efficacy claims unsupported by direct evidence. General Arabica coffee research includes large prospective cohort studies; a 2014 meta-analysis of over 28 studies found habitual coffee consumption of 3–4 cups per day associated with approximately a 25% reduced risk of type 2 diabetes compared to non-drinkers. Parkinson's disease risk reduction has been documented in prospective studies such as the Health Professionals Follow-Up Study, showing a dose-dependent inverse association with caffeine intake of roughly 300–400 mg/day. Because Maragogype beans share the Arabica species profile, these general findings are biologically plausible but cannot be attributed to the cultivar specifically without dedicated research.

## Nutritional Profile

Maragogype coffee beans share the core nutritional composition of Coffea arabica but are notable for their exceptionally large bean size ('elephant beans'), which affects extraction yield and perceived concentration per cup. Raw green Maragogype beans contain approximately 10-13% moisture, 11-13% protein (primarily storage proteins and free amino acids including glutamic acid, aspartic acid, and leucine), 15-18% lipids (predominantly triglycerides with linoleic acid ~40%, palmitic acid ~30%, oleic acid ~10%, and diterpenes cafestol and kahweol at ~0.5-1.0% of lipid fraction), and 55-65% total carbohydrates (including ~7-10% sucrose, ~30-35% polysaccharides such as galactomannans and arabinogalactans, and ~2% reducing sugars). Chlorogenic acids (primarily 5-caffeoylquinic acid) are present at 6-9% of dry weight in green beans, slightly lower than many high-altitude Arabica cultivars due to Maragogype's typically lower-altitude cultivation. Caffeine content is characteristic of Arabica at 1.0-1.4% dry weight, generally lower than Robusta. Trigonelline is present at approximately 0.6-1.2% dry weight, a precursor to niacin (vitamin B3) generated during roasting. Upon light-to-medium roasting, chlorogenic acids degrade to 3-5% of dry weight, niacin increases to approximately 10-20 mg per 100g roasted coffee, and Maillard reaction products including melanoidins (comprising ~25% of roasted bean dry weight) form with [antioxidant](/ingredients/condition/antioxidant) and [prebiotic](/ingredients/condition/gut-health) properties. A standard 240ml brewed cup yields approximately 2-5 calories, 95-150mg caffeine (slightly lower end for Arabica), 70-350mg chlorogenic acids depending on roast level, 0.1-0.3mg riboflavin (B2), 0.5mg niacin equivalents, and trace amounts of potassium (~116mg), magnesium (~7mg), and manganese (~0.1mg). The larger bean size of Maragogype relative to standard Arabica does not substantially alter per-gram nutrient density but may influence extraction dynamics, with some roasters noting the beans require adjusted grind settings. Bioavailability of chlorogenic acids from brewed coffee is estimated at 33% absorption in the small intestine with colonic fermentation of remaining fractions. No Maragogype-specific nutritional analyses have been published in peer-reviewed literature; values are extrapolated from Coffea arabica compositional databases with adjustments for known cultivar-level variability.

## Dosage & Preparation

No clinically studied dosage ranges exist for Maragogype coffee. Typically consumed as brewed beverage (1-2 cups daily as per general coffee consumption), with no standardized extract or powder forms reported. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Caffeine in Maragogype coffee, typically 80–120 mg per 8 oz cup for Arabica varieties, can cause [insomnia](/ingredients/condition/sleep), anxiety, tachycardia, and elevated blood pressure at intakes exceeding 400 mg/day in healthy adults, per FDA guidance. Caffeine interacts with adenosine-based medications, MAO inhibitors, fluoroquinolone antibiotics (which inhibit caffeine [metabolism](/ingredients/condition/weight-management) via CYP1A2), and anticoagulants such as warfarin, potentially altering their efficacy or side effect profiles. Cafestol and kahweol from unfiltered preparations can raise LDL cholesterol by up to 8–10% in individuals drinking 4–6 cups daily, relevant for those with [cardiovascular risk](/ingredients/condition/heart-health). Pregnant individuals are advised to limit total caffeine intake to under 200 mg/day (per ACOG guidelines), and those with gastroesophageal reflux, hypertension, or anxiety disorders should use caution.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses specific to Maragogype coffee were identified in biomedical databases. All available research pertains to general Coffea arabica studies without isolating this cultivar's unique traits.

## Historical & Cultural Context

Maragogype has no documented historical context in traditional medicine systems. Since its 1870 discovery, it has been valued exclusively as a specialty coffee cultivar for its large beans and unique flavor profile, not for medicinal applications.

## Synergistic Combinations

Regular Arabica coffee, Green tea extract, L-theanine, Rhodiola rosea, Dark chocolate

## Frequently Asked Questions

### What makes Maragogype coffee different from regular Arabica coffee?

Maragogype is a naturally occurring large-bean mutation of Coffea arabica first discovered in Maragogipe, Bahia, Brazil, producing beans roughly 50–75% larger than standard Arabica varieties. While it shares the same species and general bioactive compound profile—including chlorogenic acids, caffeine, and diterpenes—its flavor is often described as milder and less acidic, though no published data confirm meaningful differences in phytochemical concentrations compared to other Arabica cultivars.

### Does Maragogype coffee have more caffeine than other coffees?

There is no well-documented evidence that Maragogype beans contain significantly more or less caffeine than other Arabica varieties on a per-gram basis; Arabica coffee generally contains approximately 1.2–1.5% caffeine by dry weight compared to Robusta's 2.2–2.7%. Larger bean size does not directly translate to higher caffeine content per cup, since caffeine concentration is diluted by the greater mass. A standard 8 oz Arabica-based cup yields roughly 80–120 mg of caffeine regardless of cultivar.

### Can Maragogype coffee reduce the risk of type 2 diabetes?

General Arabica coffee consumption has been associated with reduced type 2 diabetes risk in large cohort studies, primarily through chlorogenic acid-mediated inhibition of glucose-6-phosphatase and improved insulin sensitivity. A meta-analysis published in Diabetes Care (2014) found 3–4 cups per day correlated with approximately a 25% lower diabetes risk, but these findings apply to Arabica coffee broadly. No studies have tested Maragogype coffee specifically, so direct claims about this cultivar reducing diabetes risk are not evidence-based.

### Is Maragogype coffee safe to drink every day?

For healthy, non-pregnant adults, daily consumption of Maragogype coffee in moderate amounts (up to 3–4 cups, equating to roughly 300–400 mg caffeine) is generally considered safe according to FDA and EFSA guidance. Those with hypertension, anxiety disorders, arrhythmias, or sensitivity to caffeine should limit intake, and unfiltered brewing methods (e.g., French press) increase exposure to cafestol and kahweol, which can raise LDL cholesterol with habitual use. Individuals taking CYP1A2-sensitive medications should consult a healthcare provider, as caffeine shares this metabolic pathway.

### What compounds in Maragogype coffee are responsible for its antioxidant effects?

The primary antioxidant compounds in Arabica coffee, including the Maragogype cultivar, are chlorogenic acids (mainly 5-caffeoylquinic acid), which scavenge reactive oxygen species and upregulate the Nrf2/ARE antioxidant signaling pathway. Diterpenes cafestol and kahweol also activate Nrf2-mediated phase II detoxification enzymes such as glutathione S-transferase. Roasting degree significantly impacts chlorogenic acid content, with lighter roasts retaining substantially higher concentrations—up to 7–9% of dry weight—compared to dark roasts where degradation can reduce levels by over 90%.

### How does Maragogype coffee compare to other large-bean coffee varieties?

Maragogype is distinguished by its exceptionally large bean size—roughly double that of standard Arabica beans—which results from a natural mutation first discovered in Brazil. The larger bean size affects roasting characteristics and can produce a slightly different flavor profile with some tasters noting more pronounced sweetness and complexity. However, Maragogype's nutritional composition and caffeine content per cup remain comparable to conventional Arabica varieties when brewed at standard concentrations.

### Is Maragogype coffee safe during pregnancy and breastfeeding?

Maragogype coffee contains caffeine at levels similar to regular Arabica coffee, so the same pregnancy guidelines apply—most health authorities recommend limiting caffeine intake to 200 mg daily during pregnancy. Pregnant and breastfeeding individuals should consult their healthcare provider about appropriate consumption levels. The cultivar itself presents no unique safety concerns beyond those associated with standard coffee consumption during these periods.

### What is the current quality of scientific evidence for Maragogype coffee's health effects?

No clinical trials have been conducted specifically on Maragogype coffee, so any health claims must be extrapolated from general Arabica coffee research. While broader coffee studies suggest potential benefits for type 2 diabetes and Parkinson's disease risk, these findings cannot be directly attributed to Maragogype without dedicated research. Consumers should recognize that Maragogype's purported health advantages are based on its classification as Arabica, not on evidence unique to this cultivar.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*